Google Expands AI Search and Launches Genome Research Tools
Google announced new ways to search with AI Mode and introduced public sharing capabilities for NotebookLM notebooks. The company continues building on its AI-powered search experience, which now processes over 1.5 billion monthly queries across more than 200 countries. These updates represent Google’s ongoing effort to maintain its search dominance amid growing competition from conversational AI platforms.
At AI Business Magazine, we’ve seen innovations like these take center stage at major AI conferences, where Google often outlines its long-term strategy for integrating AI into everyday workflows and scientific research. This latest rollout reinforces the company’s commitment to positioning AI not just as a convenience, but as a critical infrastructure for knowledge discovery and collaboration.
The tech giant also launched a new AI system designed to help researchers understand the human genome, expanding its reach beyond consumer applications into scientific research. This move reflects Google’s broader strategy to position AI as a tool for breakthrough discoveries across multiple fields.
AI Mode now supports more complex multi-step queries and provides better source attribution for generated responses. Users can ask follow-up questions without losing context, creating a more natural conversation flow. Google has also improved visual search capabilities, allowing users to search using images combined with text descriptions. The company reports that AI Mode reduces the need to click through multiple search results by 40%, streamlining the information discovery process.
NotebookLM’s sharing feature enables collaborative research projects, with teams able to work together on AI-generated insights from uploaded documents. Google plans to expand these capabilities to include real-time collaboration tools and integration with workspace applications. The genome research AI can identify patterns in genetic data that human researchers might miss, potentially accelerating drug discovery and personalized medicine development.
